|

²¹²Pb-DOTAM-GRPR1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Orano Med LLC1

Indications

  • mCRPC (Metastatic Castration-resistant Prostate Cancer)1
  • Nonsmall-cell Lung Cancer1
  • Colon Cancer1
  • NSCLC1
  • Glioblastoma1

Chicago, Illinois1 trial

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Northwestern University Robert H Lurie Medical Research

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.